$NVCR inks clinical trial collaboration deal to develop Tumor Treating Fields together with $MRK ’s anti-PD-1 therapy KEYTRUDA for the treatment of non-small cell lung cancer     #Novocure     #Merck   #MSD   #NSCLC   #Cancer            https://t.co/mmKTgYeEO3